Phase
Condition
N/ATreatment
Colistin Sodium Methanesulfonate plus Fosfomycin
Colistin Sodium Methanesulfonate
Clinical Study ID
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
≥ 20 years old patients who have CRAB infections (pneumonia, urinary tractinfection, skin and soft tissue infection, bloodstream infection)
Able to provide informed consent or having a legal proxy who can provide informedconsent in case the subject is unable to provide consent on his own
Exclusion
Exclusion Criteria:
Minimum inhibitory concentration (MIC) of colistin > 2 mg/L
Complicated infection with inadequate source controlled
Intracranial infection
Infective endocarditis
Intraabdominal infection
Bone and joint infection
Allergic to or have contraindication(s) to any treatment regimen in the study
Polymicrobial infection with Carbapenem-resistant Psuedomonas aeruginosa,Carbapenem-resistant Enterobacterales (CRE), Vancomycin-resistant Enterococcus (VRE)
Pregnancy
Previous treatment with colistin or fosfomycin more than 96 hours
Life expectancy of 24 hour or less
Refusal to participate in the study
Hospice treatment
Study Design
Study Description
Connect with a study center
Faculty of medicine, Chiang Mai university
Chiang Mai, 50200
ThailandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.